Drug delivery implant can help with chronic disease management – Medical News Bulletin


A recent study found that using a remote-controlled drug delivery implant can help with chronic disease management.

Millions of people worldwide suffer from chronic diseases such as rheumatoid arthritis, diabetes, and other ailments that require a lifelong treatment option.  Researchers examined the benefits of implanting a drug delivery device that can regulate and provide chronic disease management. This study used an in-vitro type of device that can release medication as the first line of treatment for high blood pressure and rheumatoid arthritis remotely.

Researchers at Houston Methodist Research Institute used a device that was remotely controlled using Bluetooth to successfully deliver continuous dosages of two chronic disease medications. The device used is called a nanochannel delivery system (nDS), and it released the medications without using pumps, valves, or a power supply. This device can be used for up to a year without any refills.

The device is battery operated and contains a microchip that relies on wireless communication. The device was implanted under the skin and programmed to release on three different drug settings: standard, decreased, and increased. This device is a step ahead compared to the medical devices that are currently on the market today. Insulin pumps or pain implants rely on either an external port or pumping mechanism that needs to be refilled every few months. These are not required for the nDS device. The benefit of this device is the medication amount and schedule can be tailored for each patient and can provide medicine for months, even years before it needs to be refilled.

Though further studies and developments may be required, this study provides a foundation for future studies on chronic disease management and the use of these kinds of medical devices.

Written by Nicole A. Brown, MS

*As an Amazon Associate, Medical News Bulletin earns from qualifying purchases. The sales made through these links help to cover the costs of maintaining this online publication. Ads are not endorsements of products, always consult your healthcare provider before taking any medications or supplements, changing your diet, or using any health-related products.


Trani, N.D., Silvestri, A., Bruno, G., Geninatti, T., …, Grattoni, A. (2019). Remotely controlled nanofluidic implantable platform for tunable drug delivery. Lab on a Chip. doi: 10.1039/c9lc00394k

Smith, G. (2019). Remote-controlled drug delivery implant size of grape may help chronic disease management. Retrieved from https://www.eurekalert.org/pub_releases/2019-06/hm-rdd062119.php

Photo credit: Houston Methodist

Source link


Articles You May Like

Exercise beneficial in relieving period pain, study finds – Medical News Bulletin
Can a dermatoscope improve early melanoma detection? – Medical News Bulletin
Does a mother’s pre-pregnancy weight influence infant growth? – Medical News Bulletin
Correlation between high-dose radiation and lung cancer survival rate – Medical News Bulletin
Is there a link between gut health and autism? – Medical News Bulletin

Leave a Reply

Your email address will not be published. Required fields are marked *